iloprost

(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid

HIFJCPQKFCZDDL-ACWOEMLNSA-N CHEBI:63916 3 Reactome links 3 studies

3 Observed studies

4 Observed diff profiles

3 Reactome pathways

Metabolite details

Identifier: HIFJCPQKFCZDDL-ACWOEMLNSA-N
InChI Key: HIFJCPQKFCZDDL-ACWOEMLNSA-N
IUPAC name: (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid
Preferred name: iloprost
INN name: iloprost
Synonym: (16R,S)-methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I₂
ChEBI: CHEBI:63916

Reactome pathways

R-HSA-109582 - Hemostasis
R-HSA-392851 - Prostacyclin signalling through prostacyclin receptor
R-HSA-418346 - Platelet homeostasis

Observed in studies

Observed in differential profiles